news
NICE recommends Liraglutide for treatment of obesity and non-diabetic hyperglycaemia
Liraglutide (Saxenda) will be offered to adults with non-diabetic hyperglycaemia and a high risk of cardiovascular disease.
List view / Grid view
Cardiovascular disease
Filter the results
article
Effect of COVID-19 on treatment of non-communicable diseases
Coronavirus or COVID-19 is currently the leading cause of mortality worldwide. With a patient database of 4,150,343 active cases (as of 28 June 2020), it is the most hit word on the internet today. Besides this catastrophe, the world has been facing a severe shortage of healthcare facilities, which has…
news
UK vaccine clinical trial outsourcing expansion continues
An outsourcing company has announced that Phase II, III and IV clinical trials of vaccines will continue at a growing number of sites, assessing the safety of each in light of COVID-19.
news
Drug approved which reduces risk of cardiovascular events
The FDA has approved Vascepa (icosapent ethyl) as a secondary therapy to reduce cardiovascular events in adults.
news
Job cuts limit cardiovascular and diabetes research and development
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
news
Benzodiazepines could decrease mortality in congestive heart failure
Researchers have suggested that benzodiazepines should be the first course of treatment for those with cardiovascular disease and anxiety...
news
Frequent aspirin use linked to increased bleeding
A study has found that long term aspirin use increases patients' risk of major bleeding events by 43 percent, with 1 in 200 having a major bleed...
news
Increasing dose of statins could save more lives
A study has shown that thousands of heart attacks and deaths caused by cardiovascular disease could be prevented through the use of statins...
news
3D bioprinting technique for artificial organ tissue and arteries
A 3D bioprinting technique could, in the future, allow the creation of human tissue structures for the analysis of various diseases...
news
Manufacturing small batches of biopharmaceuticals on demand
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease...
news
Statins study questions their widespread use in the healthy elderly
A new observational study has identified no benefit from prescribing statins to healthy pensioners aged over 75 to prevent heart disease...
news
Cardiac monitoring for high-risk breast cancer patients ‘should be prioritised’
Cardiac monitoring of high-risk breast cancer patients should be prioritised, after research revealed low rates of heart monitoring seen in the patients receiving trastuzumab.
news
Heart health calculator predicts CVD risk
A new online heart health calculator can predict the age of hearts and the risk to individuals of a serious cardiovascular event or death...
news
Canakinumab reduces gout rate by more than half
The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that canakinumab significantly reduced the rate of gout by more than half, compared to placebo, regardless of baseline serum urate level.
news
Nutrition, the microbiome, and Autism Spectrum Disorder: A review
Over the last decade, research has revealed more about the human gut microbiome—the environment within the gastrointestinal tract—where microbes, especially bacteria, reside.